Robert Takes

Prof. Dr. Robert Takes

Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Postbox 9101, 6500 HB Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
Luiz P. KowalskiLuiz P. Kowalski
Luiz P. Kowalski
Alvaro SanabriaAlvaro Sanabria
Alvaro Sanabria
JRJohn A Ridge
John A Ridge
WNWai Tong Ng
Wai Tong Ng
Remco De BreeRemco De Bree
Remco De Bree
AFAlfio Ferlito
Alfio Ferlito

14 December 2018 in Head & Neck
Verified
Journal Article
Closed access
PDF file
Fernando LõpezFernando Lõpez
Fernando Lõpez
CSCarlos Suárez
Carlos Suárez
Vincent Vander PoortenVincent Vander Poorten
Vincent Vander Poorten
AMAntti Mäkitie
Antti Mäkitie
INIain Nixon
Iain Nixon
Alfio FerlitoAlfio Ferlito
Alfio Ferlito

21 November 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
APAndres Coca Pelaz
Andres Coca Pelaz
Juan Pablo Rodrigo TapiaJuan Pablo Rodrigo Tapia
Juan Pablo Rodrigo Tapia
CSCarlos Suárez
Carlos Suárez
INIain Nixon
Iain Nixon
AMAntti Mäkitie
Antti Mäkitie
AFAlfio Ferlito
Alfio Ferlito

3 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
ITInne J. Den Toom
Inne J. Den Toom
KBKoos Boeve
Koos Boeve
DLDaphne Lobeek
Daphne Lobeek
Elisabeth BloemenaElisabeth Bloemena
Elisabeth Bloemena
MDMaarten Lucas Donswijk
Maarten Lucas Donswijk
Remco De BreeRemco De Bree
Remco De Bree
Background: Sentinel lymph node biopsy (SLNB) has been introduced as a diagnostic staging modality for detection of occult metastases in patients with early stage oral cancer. Comparisons regarding accuracy to the routinely used elective neck dissection (END) are lacking in literature. Methods: A retrospective, multicenter cohort study included 390 patients staged by END and 488 by SLNB. Results: The overall sensitivity (84% vs. 81%, p = 0.612) and negative predictive value (NPV) (93%, p = 1.000) were comparable between END and SLNB patients. The END cohort contained more pT2 tumours (51%) compared to the SLNB cohort (23%) (p < 0.001). No differences were found for sensitivity and NPV between SLNB and END divided by pT stage. In floor-of-mouth (FOM) tumours, SLNB had a lower sensitivity (63% vs. 92%, p = 0.006) and NPV (90% vs. 97%, p = 0.057) compared to END. Higher disease-specific survival (DSS) rates were found for pT1 SLNB patients compared to pT1 END patients (96% vs. 90%, p = 0.048). Conclusion: In the absence of randomized clinical trials, this study provides the highest available evidence that, in oral cancer, SLNB is as accurate as END in detecting occult lymph node metastases, except for floor-of-mouth tumours.

13 August 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
MQMiquel Quer
Miquel Quer
JHJuan C. Hernandez-Prera
Juan C. Hernandez-Prera
CSCarl E. Silver
Carl E. Silver
MCMaria Casasayas
Maria Casasayas
RSRicard Simo
Ricard Simo
Alfio FerlitoAlfio Ferlito
Alfio Ferlito
Purpose: To review the current options in the management of Warthin tumors (WTs) and to propose a working management protocol. Methods: A systematic literature search was conducted using PubMed and ScienceDirect database. A total of 141 publications were selected and have been included in this review. Publications were selected based on relevance, scientific evidence, and actuality. Results: The importance of parotid WTs is increasing due to its rising incidence in many countries, becoming the most frequently encountered benign parotid tumor in certain parts of the world. In the past, all WTs were treated with surgery, but because of their slow growth rate, often minimal clinical symptoms, and the advanced age of many patients, active observation has gradually become more widely used. In order to decide on active surveillance, the diagnosis of WT must be reliable, and clinical, imaging, and cytological data should be concordant. There are four clear indications for upfront surgery: uncertain diagnosis; cosmetic problems; clinical complaints, such as pain, ulceration, or recurrent infection; and the patient’s wish to have the tumor removed. In the remaining cases, surgery can be elective. Active surveillance is often suggested as the first approach, with surgery being considered if the tumor progresses and/or causes clinical complaints. The extent of surgery is another controversial topic, and the current trend is to minimize the resection using partial parotidectomies and extracapsular dissections when possible. Recently, non-surgical options such as microwave ablation, radiofrequency ablation, and ultrasound-guided ethanol sclerotherapy have been proposed for selected cases. Conclusions: The management of WT is gradually shifting from superficial or total parotidectomy to more conservative approaches, with more limited resections, and to active surveillance in an increasing number of patients. Additionally, non-surgical treatments are emerging, but their role needs to be defined in future studies.

24 April 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Alvaro SanabriaAlvaro Sanabria
Alvaro Sanabria
JSJatin P. Shah
Jatin P. Shah
JMJesus E. Medina
Jesus E. Medina
KOKerry D. Olsen
Kerry D. Olsen
KRKevin Robbins
Kevin Robbins
Alfio FerlitoAlfio Ferlito
Alfio Ferlito
Background: Larynx cancer is a common site for tumors of the upper aerodigestive tract. In cases with a clinically negative neck, the indications for an elective neck treatment are still debated. The objective is to define the prevalence of occult metastasis based on the subsite of the primary tumor, T classification and neck node levels involved. Methods: All studies included provided the rate of occult metastases in cN0 larynx squamous cell carcinoma patients. The main outcome was the incidence of occult metastasis. The pooled incidence was calculated with random effects analysis. Results: 36 studies with 3803 patients fulfilled the criteria. The incidence of lymph node metastases for supraglottic and glottic tumors was 19.9% (95% CI 16.4–23.4) and 8.0% (95% CI 2.7–13.3), respectively. The incidence of occult metastasis for level I, level IV and level V was 2.4% (95% CI 0–6.1%), 2.0% (95% CI 0.9–3.1) and 0.4% (95% CI 0–1.0%), respectively. For all tumors, the incidence for sublevel IIB was 0.5% (95% CI 0–1.3). Conclusions: The incidence of occult lymph node metastasis is higher in supraglottic and T3–4 tumors. Level I and V and sublevel IIB should not be routinely included in the elective neck treatment of cN0 laryngeal cancer and, in addition, level IV should not be routinely included in cases of supraglottic tumors.